Inventor
TSO KIN
US55 patents
⚠️ This page may combine multiple inventors who share the name “TSO KIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RIGEL PHARMACEUTICALS INC
38 patentsUS7858633B2Dec 28, 2010
Cycloalkyl substituted pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC66 citations98
US7834024B2Nov 16, 2010
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC59 citations97
US7754714B2Jul 13, 2010
Cycloalkyl substituted pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC39 citations95
US7915273B2Mar 29, 2011
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC33 citations93
US9982000B2May 29, 2018
Pyrazole compounds and method for making and using the compounds
RIGEL PHARMACEUTICALS INC16 citations92
US7868013B2Jan 11, 2011
Cycloalkyl substituted pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC25 citations91
US10421752B2Sep 24, 2019
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC3 citations84
US10208075B2Feb 19, 2019
Pyrazole compounds and method for making and using the compounds
RIGEL PHARMACEUTICALS INC4 citations84
US10208074B2Feb 19, 2019
Pyrazole compounds and method for making and using the compounds
RIGEL PHARMACEUTICALS INC5 citations84
US9732073B2Aug 15, 2017
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC4 citations84
US9725419B2Aug 8, 2017
Cycloalkyl substituted pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC7 citations84
US9566278B2Feb 14, 2017
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC6 citations84
US9321763B2Apr 26, 2016
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC6 citations84
US9248190B2Feb 2, 2016
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC4 citations84
US8815848B2Aug 26, 2014
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC8 citations84
US8377924B2Feb 19, 2013
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC9 citations82
US11530194B2Dec 20, 2022
Amide compounds and method for making and using
RIGEL PHARMACEUTICALS INC1 citations73
US11492349B2Nov 8, 2022
IRAK inhibitors and method for making and using
RIGEL PHARMACEUTICALS INC1 citations73
US11198689B2Dec 14, 2021
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC2 citations73
US10947216B2Mar 16, 2021
Amide compounds and method for making and using
RIGEL PHARMACEUTICALS INC1 citations73
US10941140B2Mar 9, 2021
IRAK inhibitors and method for making and using
RIGEL PHARMACEUTICALS INC2 citations73
US10414753B2Sep 17, 2019
Amide compounds and method for making and using
RIGEL PHARMACEUTICALS INC1 citations73
US10370367B2Aug 6, 2019
IRAK inhibitors and method for making and using
RIGEL PHARMACEUTICALS INC1 citations73
US9913843B2Mar 13, 2018
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC3 citations73
US9732070B2Aug 15, 2017
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC4 citations73
US9682976B2Jun 20, 2017
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC3 citations73
US9481654B2Nov 1, 2016
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC5 citations73
US9169249B2Oct 27, 2015
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC4 citations73
US9149475B2Oct 6, 2015
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC5 citations71
US11827628B2Nov 28, 2023
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC0 citations63
US11667611B2Jun 6, 2023
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC0 citations63
US11993594B2May 28, 2024
IRAK inhibitors and method for making and using
RIGEL PHARMACEUTICALS INC0 citations62
US11939317B2Mar 26, 2024
Amide compounds and method for making and using
RIGEL PHARMACEUTICALS INC0 citations62
US11370808B2Jun 28, 2022
Pyrazole compounds and methods for making and using the compounds
RIGEL PHARMACEUTICALS INC0 citations62
US10792282B2Oct 6, 2020
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC0 citations52
US10005777B2Jun 26, 2018
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC0 citations52
US9062068B2Jun 23, 2015
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC0 citations52
US9040543B2May 26, 2015
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC0 citations52
LI HUI
8 patentsUS8415365B2Apr 9, 2013
Compositions and methods for inhibition of the JAK pathway
LI HUI31 citations96
US8399472B2Mar 19, 2013
Compositions and methods for inhibition of the JAK pathway
LI HUI26 citations96
US8193197B2Jun 5, 2012
Compositions and methods for inhibition of the JAK pathway
LI HUI17 citations93
US8410093B2Apr 2, 2013
Cycloalkyl substituted pyrimidinediamine compounds and their uses
LI HUI9 citations84
US8299087B2Oct 30, 2012
Compositions and methods for inhibition of the JAK pathway
LI HUI11 citations84
US8962643B2Feb 24, 2015
Compositions and methods for inhibition of the JAK pathway
LI HUI3 citations63
US8334297B2Dec 18, 2012
2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
LI HUI5 citations60
US8729087B2May 20, 2014
Compositions and methods for inhibition of the JAK pathway
LI HUI0 citations52
EXELIXIS INC
1 patentARGADE ANKUSH
1 patentSINGH RAJINDER
1 patentGURURAJA TARIKERE
1 patentShowing the top 50 of 55 patents by PatentIndex Score.